| 英文名称 |
中文名称 |
CAS |
|
Pluronic F-127 Cell Culture Tested - 10 g
|
泊洛沙姆188 |
9003-11-6 |
|
Proinsulin C-peptide (55-89), human - 0.5 mg
|
C-PEPTIDE (1-35), HUMAN |
11097-48-6 |
|
Protease-Activated Receptor-4, PAR-4 Agonist, amide
|
AY-NH2 |
352017-71-1 |
|
Proadrenomedullin N-term peptide, PAMP (1-20) - 5 mg
|
肾上腺髓质素N端20肽（人类） |
150238-87-2 |
|
Pluronic F-127, 20 % solution in DMSO - 10 ml
|
|
|
|
Rev4
|
|
|
|
PrP (106-126), prion protein - 1 mg
|
PRION PROTEIN (106-126) (HUMAN) |
148439-49-0 |
|
SARS-CoV-2 Spike receptor binding domain, RBD (348-357) - 0.5 mg
|
|
|
|
Protein A-HiLyte Fluor 488 Conjugate - 1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - 0.5 mg
|
|
|
|
QXL 490 acid, SE - 5 mg
|
|
|
|
SARS-CoV Peptide Antigen Negative control - 1mg NET peptide
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (523-541) - 0.5 mg
|
|
|
|
Protease-Activated Receptor-2, PAR-2 Agonist 2, amide - 5 mg
|
H-丝氨酰亮氨酰异亮氨酰甘氨酰赖氨酰缬氨酰NH2 |
190383-13-2 |
|
Recombinant mouse MOG (1-125)
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - 0.5 mg
|
|
|
|
Renin FRET substrate, Dabcyl/EDANS - 1 mg
|
DABCYL-GAMMA-ABU-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-THR-EDANS |
142988-22-5 |
|
Renin Substrate, Angiotensinogen (1-14), rat - 1 mg
|
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-LEU-TYR-TYR-SER |
110200-37-8 |
|
SARS-CoV-2 Spike receptor binding domain, RBD (523-541) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
QXL 570 acid, SE - 5 mg
|
|
|
|
Protein A-Biotin Conjugate - 5 mg
|
|
|
|
R-PE (R-Phycoerythrin) - 1 mg
|
|
|
|
Recombinant rat MOG (1-125)
|
|
|
|
pVEC (Cadherin-5) - 1 mg
|
|
|
|
SAMS Peptide [HMRSAMSGLHLVKRR-NH2] - 5 mg
|
|
|
|
Proteases Substrate, Fluorogenic, (Z-R)2Rh1102HCl - 5 mg
|
|
|
|
Protease-Activated Receptor-4, PAR-4 Agonist 3, amide, murine - 1 mg
|
GLY-TYR-PRO-GLY-LYS-PHE-NH2 |
245443-52-1 |
|
Protease-Activated Receptor-1, PAR-1 Antagonist 2, amide - 1 mg
|
|
|
|
PUMA BH3 - 1 mg
|
|
|
|
RS domain derived peptide - 1 mg
|
|
|
|
Prodan [6-Propionyl-2-dimethylaminonaphthalene] - 25 mg
|
N,N-二甲基-6-丙酰-2-萘胺 |
70504-01-7 |
|
QXL 570 C2 maleimide - 5 mg
|
|
|
|
Resorufin -D-Galactopyranoside - 25 mg
|
试卤灵Β-D-半乳糖吡喃糖苷 |
95079-19-9 |
|
SAMs peptide, FAM labeled - 1 mg
|
|
|
|
Protease-Activated Receptor-3, PAR-3 (1-6), human - 1 mg
|
COAGULATION FACTOR II RECEPTOR-LIKE 2 (1-6) AMIDE (HUMAN) |
1872435-09-0 |
|
Poly-gamma-D-Glutamic Acid Construct - 1 mg
|
|
|
|
PSTi8, 1mg
|
|
|
|
Prostatic Acid Phosphatase (248-286), PAP (248-286) - 1 mg
|
|
|
|
Rhod-2, AM UltraPure Grade - 1 mg
|
RHOD-2, AM |
145037-81-6 |
|
SARS-CoV-2 Spike receptor binding domain, RBD (319-335) - 0.5 mg
|
|
|
|
Proinsulin C-peptide (55-87), porcine - 0.5 mg
|
ARG-ARG-GLU-ALA-GLU-ASN-PRO-GLN-ALA-GLY-ALA-VAL-GLU-LEU-GLY-GLY-GLY-LEU-GLY-GLY-LEU-GLN-ALA-LEU-ALA-LEU-GLU-GLY-PRO-PRO-GLN-LYS-ARG |
28152-90-1 |
|
RGD-4C - 5 mg
|
|
|
|
SARS-CoV Peptide Antigen I - 1mg NET peptide
|
|
|
|
Rhodopsin Epitope Tag - 5 mg
|
|
|
|
S3 Fragment, ADF/cofilin, LIMK1 substrate - 1 mg
|
|
|
|
Protease-Activated Receptor-1, PAR-1 Antagonist 1 - 1 mg
|
H-TYR-PHE-LEU-LEU-ARG-ASN-PRO-OH |
149440-16-4 |
|
Ryanodine receptor 1 (RyR1) (3614-3643), Calmodulin Binding Peptide (CaMBP) - 1 mg
|
|
|
|
S6 Kinase Substrate (229-239)
|
ALA-LYS-ARG-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA |
|
|
Pramlintide, Acetate [Pro25, 28, 29]-Amylin(1-37), human, Amide - 1 mg
|
醋酸普兰林肽 |
196078-30-5 |
|
Rat Renin, recombinant - 20 μg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
Proapoptotic Peptide, (klaklak)2, 5-FAM-labeled - 1 mg
|
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist - 1 mg
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 - 0.5 mg
|
|
|
|
SARS-CoV T-cell Peptide Antigens Set - 0.25 mg Net
|
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist 2, amide - 1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (348-357)- Lys(Biotin-LC) - 0.1 mg
|
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist 1, amide - 5 mg
|
|
|
|
SARS-CoV Peptide Antigen Positive control - 1mg NET peptide
|
|
|
|
Protein A-HiLyte Fluor 555 Conjugate - 1 mg
|
|
|
|
Protegrin-1 (PG-1), amide
|
|
|
|
Protease-Activated Receptor-3, PAR-3 Agonist, amide - 1 mg
|
SER-PHE-ASN-GLY-GLY-PRO-NH2 |
261521-21-5 |
|
Protein A-HiLyte Fluor 647 Conjugate - 1 mg
|
|
|
|
RH414 - 5 mg
|
Neurodye RH-414, pure |
161433-30-3 |
|
SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - 0.5 mg
|
|
|
|
pp60(v-SRC) Autophosphorylation Site, Phosphorylated - 1 mg
|
|
|
|
QXL 490 acid - 10 mg
|
|
|
|
Propidium iodide, 1.0 mg/mL solution in water - 10 ml
|
碘化丙啶 |
25535-16-4 |
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - 0.5 mg
|
|
|
|
Protein A-HiLyte Fluor 750 Conjugate - 1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
Prosaptide TX14(A)
|
THR-D-ALA-LEU-ILE-ASP-ASN-ASN-ALA-THR-GLU-GLU-ILE-LEU-TYR |
196391-82-9 |
|
Quinine sulfate Fluorescence Reference Standard - 100 mg
|
硫酸奎宁 |
6119-70-6 |
|
Rabies Virus Glycoprotein (RVG) - 1 mg
|
|
|
|
Recombinant human MOG (1-125)
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (319-335) -Lys(Biotin-LC) - 0.1 mg
|
|
|
|
QXL 570 acid - 10 mg
|
|
|
|
Pyrrhocoricin - 1 mg
|
PYRRHOCORICIN |
156548-23-1 |
|
Renin Inhibitor Peptide, WFML Peptide, rat - 1 mg
|
|
|
|
PMAP-23
|
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist 3, amide - 1 mg
|
|
|
|
Renin FRET Substrate (5-FAM/QXL 520) - 0.1 mg
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - 0.5 mg
|
|
|
|
Pluronic F-127, 10 % solution in water - 100 ml
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (513-520) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - Lys(Biotin-LC) - 0.1 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - 0.5 mg
|
|
|
|
SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - 0.5 mg
|
|
|
|
pro-NPY peptide (34-43), human - 0.1 mg
|
|
|
|
Protease-Activated Receptor-2, PAR-2 Agonist, amide - 1 mg
|
2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2 |
729589-58-6 |
|
Protease-Activated Receptor-4, PAR-4 Antagonist, amide - 1 mg
|
反-肉桂酰-TYR-PRO-GLY-LYS-PHE-酰胺三氟乙酸盐 |
327177-34-4 |
|
Renin FRET Substrate, R-E(EDANS)--K(Dabcyl) - 1 mg
|
Renin Substrate 1 trifluoroacetate salt |
791068-69-4 |
|
QXL 670 acid, SE - 5 mg
|
|
|
|
Renin FRET Substrate (5-FAM/QXL 520), rat - 0.1 mg
|
|
|
|
RGDS - 5 mg
|
Arg-Gly-Asp-Ser |
91037-65-9 |
|
Renin Substrate, Angiotensinogen (1-14), human - 1 mg
|
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN |
104180-23-6 |
|
SARS-CoV-2 Spike receptor binding domain, RBD (513-520) - 0.5 mg
|
|
|
|
Proapoptotic Peptide, (klaklak)2 - 1 mg
|
|
|
|
S6 Kinase Substrate (229-239), Amide, Biotinalyted - 1 mg
|
|
|
